{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:24:00Z","timestamp":1760235840527,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>This paper aims to analyse the consumption of antibiotics in the Slovak health care system from 2011 to 2020. The data source on the consumption of antibiotics is sales data from SUKL and NCZI. The study employed the ATC\/DDD Index and focused on the consumption of antibiotics in the primary care sector. Total antibiotic consumption decreased from 19.21 DID in 2011 to 13.16 DID in 2020. Consumption of beta-lactamase-sensitive penicillins, expressed as a percentage of the total consumption of antibiotics, decreased from 8.4% in 2011 to 4.2% in 2020. Consumption of the combination of penicillins, including beta-lactamase inhibitor, expressed as a percentage of the total consumption of antibiotics, increased from 16.2% in 2011 to 17.9% in 2020. Consumption of third- and fourth-generation cephalosporins, expressed as the percentage of the total consumption of antibiotics, increased from 2.0% in 2011 to 4.6% in 2020. Consumption of fluoroquinolones, expressed as the percentage of the total consumption of antibiotics, decreased from 10.7% in 2011 to 8.6% in 2020. Overall, antibiotic consumption significantly changed in Slovakia from 2011 to 2020. The ratio of the consumption of broad-spectrum to the consumption of narrow-spectrum penicillins, cephalosporins and macrolides decreased from 14.98 in 2011 to 13.38 in 2020.<\/jats:p>","DOI":"10.3390\/antibiotics10101180","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T12:29:14Z","timestamp":1632832154000},"page":"1180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Consumption of Antibacterials for Systemic Use in Slovakia: A National Study and the Quality Indicators for Outpatient Antibiotic Use"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0023-4574","authenticated-orcid":false,"given":"Tomas","family":"Tesar","sequence":"first","affiliation":[{"name":"Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Masarykova","sequence":"additional","affiliation":[{"name":"Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubica","family":"Lehocka","sequence":"additional","affiliation":[{"name":"Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slavka","family":"Porubcova","sequence":"additional","affiliation":[{"name":"Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Cicova","sequence":"additional","affiliation":[{"name":"Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wawruch","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"ref_1","first-page":"210","article-title":"Slovakia: Health system review","volume":"18","author":"Smatana","year":"2016","journal-title":"Health Syst. Transit."},{"key":"ref_2","unstructured":"Ministry of Health (2021, May 31). Act No. 363\/2011 Coll. on the Scope and Conditions of Payments for Medicines, Medical Devices and Dietetic Foods from Public Health Insurance and Amending Certain Acts, as Amended. Available online: http:\/\/www.zakonypreludi.sk\/zz\/2011-363."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fphar.2019.00664","article-title":"How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia","volume":"10","author":"Tesar","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3201\/eid1411.070467","article-title":"Antimicrobial drug use and resistance in Europe","volume":"14","author":"Grundmann","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"639207","DOI":"10.3389\/fphar.2021.639207","article-title":"Variations in the consumption of antimicrobial medicines in the European region, 2014\u20132018: Findings and implications from ESAC-Net and WHO Europe","volume":"12","author":"Robertson","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1093\/jac\/dkab174","article-title":"Consumption of cephalosporins in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Versporten","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"ii37","DOI":"10.1093\/jac\/dkab176","article-title":"Consumption of quinolones in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Adriaenssens","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis","volume":"9","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41579-018-0125-x","article-title":"The cost of antimicrobial resistance","volume":"17","author":"Hofer","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3389\/fphar.2018.01156","article-title":"Antimicrobial Medicines Consumption in Eastern Europe and Central Asia\u2014An Updated Cross-National Study and Assessment of Quantitative Metrics for Policy Action","volume":"9","author":"Robertson","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijantimicag.2016.06.015","article-title":"Ten key points for the appropriate use of antibiotics in hospitalised patients: A consensus from the Antimicrobial Stewardship and Resistance Working Groups of the International Society of Chemotherapy","volume":"48","author":"Kanj","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0974-777X.112261","article-title":"State of the globe: Antimicrobial stewardship guides rationale use of antimicrobials to enable faster cure and prevent drug resistance","volume":"5","author":"Kelkar","year":"2013","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_13","unstructured":"European Commission (2021, May 31). Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions, Pharmaceutical Strategy for Europe {SWD (2020) 286 final}. Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/ALL\/?uri=COM:2020:0761:FIN."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.addr.2005.04.005","article-title":"Clinical impact and relevance of antibiotic resistance","volume":"57","author":"French","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13756-018-0428-8","article-title":"Antibiotic consumption and antimicrobial resistance in Poland; findings and implications","volume":"7","author":"Godman","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ii7","DOI":"10.1093\/jac\/dkab172","article-title":"Consumption of antibiotics in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Bruyndonckx","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1093\/jac\/dkab173","article-title":"Consumption of penicillins in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Bruyndonckx","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1093\/jac\/dkab175","article-title":"Consumption of macrolides, lincosamides and streptogramins in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Adriaenssens","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","unstructured":"European Medicines Agency (2021, September 10). Disabling and Potentially Permanent Side Effects Lead to Suspension or Restrictions of Quinolone and Fluoroquinolone Antibiotics. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/quinolone-fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"ii45","DOI":"10.1093\/jac\/dkab177","article-title":"Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union\/European Economic Area, 1997\u20132017","volume":"76","author":"Versporten","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.5694\/mja17.00574","article-title":"Reducing antibiotic prescribing in Australian general practice: Time for a national strategy","volume":"207","author":"Scott","year":"2017","journal-title":"Med. J. Aust."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"A309","DOI":"10.1016\/S1098-3015(10)65118-2","article-title":"S-meddial project of cooperation with pediatricians on providing individual feedback on antibiotics prescription in order to improve prescription habits and to rationalize drug spending","volume":"6","author":"Hupkova","year":"2007","journal-title":"Value Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"A204","DOI":"10.1016\/S1098-3015(10)72998-3","article-title":"Integrated educational project with individual feedback from claims data leads to improved antibiotic prescription and resistance decrease","volume":"3","author":"Hupkova","year":"2010","journal-title":"Value Health"},{"key":"ref_24","first-page":"123","article-title":"Antibiotic prescription as a public health care issue","volume":"7\u20138","year":"2012","journal-title":"Slovensk\u00fd lek\u00e1r"},{"key":"ref_25","unstructured":"Health Insurance Fund Trust (2021, May 31). Where Do We Pay the Most for Antibiotics?. Available online: https:\/\/www.dovera.sk\/aktuality\/3707-kde-platime-za-antibiotika-najviac-pozrite-sa-na-mape."},{"key":"ref_26","first-page":"635","article-title":"The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia","volume":"372","author":"Pavelka","year":"2020","journal-title":"medRxiv"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(20)32261-3","article-title":"Slovakia to test all adults for SARS-CoV-2","volume":"396","author":"Holt","year":"2020","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/idr13010007","article-title":"On Pilot Massive COVID-19 Testing by Antigen Tests in Europe. Case Study: Slovakia","volume":"13","author":"Frnda","year":"2021","journal-title":"Infect. Dis. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/iub.2356","article-title":"Bacterial co-infections with SARS-CoV-2","volume":"72","author":"Mirzaei","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/qshc.2006.021121","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): Quality indicators for outpatient antibiotic use in Europe","volume":"16","author":"Coenen","year":"2007","journal-title":"Qual. Saf. Health Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"ii60","DOI":"10.1093\/jac\/dkab178","article-title":"Quality appraisal of antibiotic consumption in the community, European Union\/European Economic Area, 2009 and 2017","volume":"76","author":"Adriaenssens","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1473-3099(20)30332-7","article-title":"Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000\u20132015: An analysis of pharmaceutical sales data","volume":"21","author":"Klein","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_33","unstructured":"European Centre for Disease Prevention and Control (2021, May 31). Surveillance of Antimicrobial Resistance in Europe 2018. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/surveillance-antimicrobial-resistance-Europe-2018.pdf."},{"key":"ref_34","unstructured":"World Health Organization (2021, May 31). AWaRe Classification Database. Available online: https:\/\/www.who.int\/medicines\/news\/2019\/WHO_releases2019AWaRe_classification_antibiotics\/en\/."},{"key":"ref_35","unstructured":"European Centre for Disease Prevention and Control European Food Safety Authority and European Medicines Agency (2021, May 31). ECDC\/EFSA\/EMA Second Joint Report on the Integrated Analysis of the Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Humans and Food-Producing Animals\u2014Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA) Report 2017. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/ecdcefsaema-second-joint-report-integrated-analysis-consumption-antimicrobial."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e012244","DOI":"10.1136\/bmjopen-2016-012244","article-title":"Why do general practitioners prescribe antibiotics for upper respiratory tract infections to meet patient expectations: A mixed methods study","volume":"6","author":"Yee","year":"2016","journal-title":"BMJ Open"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1037\/hea0000456","article-title":"Expectations for antibiotics increase their prescribing: Causal evidence about localized impact","volume":"36","author":"Sirota","year":"2017","journal-title":"Health Psychol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s10096-019-03572-5","article-title":"The use of a poster to reduce expectations to receive antibiotics for a common cold","volume":"38","author":"Ritchie","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_39","unstructured":"State Institute for Drug Control (2021, May 31). About SIDC. Available online: https:\/\/www.sukl.sk\/hlavna-stranka\/english-version\/about-sidc?page_id=259."},{"key":"ref_40","unstructured":"MCR (2021, May 31). Consumption of Medicinal Products in Slovakia. Available online: https:\/\/www.mcr.sk\/spotreba-liekov-na-slovensku\/."},{"key":"ref_41","unstructured":"National Health Information Centre (2021, May 31). About NHIC, Available online: http:\/\/www.nczisk.sk\/en\/Pages\/default.aspx."},{"key":"ref_42","unstructured":"European Centre for Disease Prevention and Control European Food Safety Authority and European Medicines Agency (2021, May 31). ECDC, EFSA and EMA Joint Scientific Opinion on a List of Outcome Indicators as Regards Surveillance of Antimicrobial Resistance and Antimicrobial Consumption in Humans and Food-Producing Animals. Available online: https:\/\/www.efsa.europa.eu\/en\/efsajournal\/pub\/5017."},{"key":"ref_43","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2021, May 31). ATC Classification Index with DDDs 2021. Available online: https:\/\/www.whocc.no\/."},{"key":"ref_44","unstructured":"European Surveillance of Antimicrobial Consumption Network (ESAC-Net) (2021, May 31). Antimicrobial Consumption (AMC) Reporting Protocol. Available online: https:\/\/www.ecdc.europa.eu\/en\/antimicrobial-consumption\/surveillance-and-disease-data\/report-protocol."},{"key":"ref_45","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2021, May 31). Antimicrobial Consumption Database (ESAC-Net). Available online: https:\/\/www.ecdc.europa.eu\/en\/antimicrobial-consumption\/surveillance-and-disease-data\/database."},{"key":"ref_46","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2021, May 31). The European Surveillance System (TESSy). Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/european-surveillance-system-tessy."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/10\/1180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:06:32Z","timestamp":1760166392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/10\/1180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["antibiotics10101180"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics10101180","relation":{},"ISSN":["2079-6382"],"issn-type":[{"type":"electronic","value":"2079-6382"}],"subject":[],"published":{"date-parts":[[2021,9,28]]}}}